2008
DOI: 10.1111/j.1464-410x.2008.07970.x
|View full text |Cite
|
Sign up to set email alerts
|

Chemoprevention of bladder cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
4
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 37 publications
0
4
0
Order By: Relevance
“…If these foods or compounds do indeed prove to demonstrate clear and potent bioactivity, they can be utilized to improve upon the bladder cancer burden in several ways. One strategy would be “primary” chemoprevention by targeting high‐risk populations, such as heavy smokers and those with environmental/occupational exposures . Another strategy is a “tertiary” chemopreventive approach, in patients who have a successful complete cystoscopic resection of their superficial bladder cancer.…”
Section: Concluding Thoughtsmentioning
confidence: 99%
See 1 more Smart Citation
“…If these foods or compounds do indeed prove to demonstrate clear and potent bioactivity, they can be utilized to improve upon the bladder cancer burden in several ways. One strategy would be “primary” chemoprevention by targeting high‐risk populations, such as heavy smokers and those with environmental/occupational exposures . Another strategy is a “tertiary” chemopreventive approach, in patients who have a successful complete cystoscopic resection of their superficial bladder cancer.…”
Section: Concluding Thoughtsmentioning
confidence: 99%
“…One strategy would be "primary" chemoprevention by targeting high-risk populations, such as heavy smokers and those with environmental/occupational exposures. [181] Another strategy is a "tertiary" chemopreventive approach, in patients who have a successful complete cystoscopic resection of their superficial bladder cancer. In this case, the goal is to reduce or eliminate the wellknown high risk of recurrent tumors and the progression to invasive disease.…”
Section: Concluding Thoughtsmentioning
confidence: 99%
“…The association between the use of different types of analgesics and BC risk is controversial. On the one hand, there was strong experimental and epidemiological evidence that nonsteroidal anti-inflammatory drugs (NSAIDs) and cyclooxygenase 2 (COX-2) inhibitors might have a potential as cancer chemopreventive agents [ 29 ]. For example, ibuprofen, naproxen, indomethacin, piroxicam, and celecoxib inhibit BC development in a variety of human and animal models [ 29 , 30 ].…”
Section: Discussionmentioning
confidence: 99%
“…On the one hand, there was strong experimental and epidemiological evidence that nonsteroidal anti-inflammatory drugs (NSAIDs) and cyclooxygenase 2 (COX-2) inhibitors might have a potential as cancer chemopreventive agents [ 29 ]. For example, ibuprofen, naproxen, indomethacin, piroxicam, and celecoxib inhibit BC development in a variety of human and animal models [ 29 , 30 ]. However, other studies describe an increased risk of BC associated with the use of phenacetin-containing analgesics, particularly with longer use.…”
Section: Discussionmentioning
confidence: 99%